Introduction {#S1}
============

Bone conduction (BC) hearing provides a different pathway for sound transmission and represents an alternative to physiologic airborne conduction [@R01] [@R02]. Although the actual mechanisms that produce the hearing sensation when sound is transmitted through bone have not being fully elucidated, bone conduction hearing devices, such as conventional hearing aids (HA) or bone-conductive implants (BCI), have allowed to overcome some limitations that an air conduction HA carries in relation to, for example, post-operative sequels from middle ear surgery or external ear canal chronic diseases [@R03] [@R04]. In fact, in the last decades, BCI have been successfully applied not only to patients with conductive or mixed hearing loss of different aetiology, but also to those affected by single-sided sensorineural deafness (SSD) by reproducing a contralateral routing of offside signal (CRO S) amplification [@R05]. For nearly three decades, percutaneous BCIs have been adopted worldwide, allowing the osseointegrated device to directly drive bone stimulation to the cochlea, bypassing the damping effect of the skin and subcutaneous tissue. In case of small children, in whom reduced skull thickness is unlikely to retain the implanted screw, the BC sound processor is usually stabilised with a band, called soft-band, that provides transcutaneous stimulation. Likewise, a transcutaneous BC variant, coupled to the HB, is routinely used during the selection process of potential candidates, since it allows not only to perform the audiological evaluation, but also permits patients to familiarise themselves and subjectively perceive its possible benefit.

It is general opinion that the functional outcome of a transcutaneous bone-conductive system is different from what can be achieved by an osseointegrated implant. The variables in play for the reduced performance of the transcutaneous stimulation are position of the bone vibrator, surface contact area, skin thickness and frequency stimulation. In particular, when considering the frequency range of transmission of osteointegrated and transcutaneous BC devices, an overlapping sensitivity has to be expected below 500 Hz since, up to this frequency, the interposed skin produces no attenuation [@R06]. Beyond 500 Hz, contrarily, progressive separation of the percutaneous and transcutaneous BC thresholds occurs, the former being superior by approximately 4 to 7 dB when the speech reception threshold values are considered [@R06].

The present study was performed to assess the clinical validity of carrying out the preoperative simulation test with HB, when the coupled sound processor has been customised to the patient\'s hearing loss and auditory targets, as a reliable predictor of the final outcome of BCI.

Materials and methods {#S2}
=====================

Twenty-two adult subjects (10 males, 12 females), implanted at a University Hospital Implanting Center with a single BCI system (BAHA^®^, Cochlear, Mölnlycke, Sweden) were included in this retrospective study ([Table I](#T1){ref-type="table"}). Thirteen subjects presented with conductive-mixed hearing loss (CMHL), with mean bone-conduction threshold of 36.5 dB, mean air-conduction threshold of 73.1 dB and mean airbone gap of 36.6 dB; 9 subjects were affected by single sided deafness (SSD), with a contralateral mild, downsloping sensorineural hearing loss presumably caused by aging ([Table II](#T2){ref-type="table"}). A BP100 sound processor (SP) was used in 10 patients and a Divino SP in the remaining 12.

###### 

Demographics and clinical characteristics of subjects included in the study. M: male; F: female; COM: chronic otitis media; SSD: single sided deafness.

  Patient   Age   Gender   Aetiology             Type of hearing loss
  --------- ----- -------- --------------------- ----------------------
  A.M.      53    F        Bilateral COM         Mixed bilateral
  G.B.      52    M        Right COM             Mixed right
  R.B.      40    F        Bilateral COM         Mixed bilateral
  M.C.      35    M        Franceschetti S.      Mixed bilateral
  B.C.      35    F        Bilateral COM         Mixed bilateral
  V.E.      45    F        Right COM             Mixed right
  A.F.      56    F        Bilateral COM         Mixed bilateral
  C.M.      56    F        Bilateral COM         Mixed bilateral
  A.T.      63    F        Bilateral COM         Mixed bilateral
  A.R.2     63    F        Bilateral COM         Mixed bilateral
  A.R.1     51    M        Goldenhar S.          Mixed bilateral
  V.S.      51    M        Bilateral COM         Mixed bilateral
  L.T.      55    F        Bilateral COM         Mixed bilateral
  C.T.      57    F        Sudden hearing loss   SSD
  S.A.      60    M        Sudden hearing loss   SSD
  S.A.      64    F        Ear surgery           SSD
  R.F.      51    M        Ear surgery           SSD
  E.M.      66    F        Ear surgery           SSD
  DBL       57    M        Ear surgery           SSD
  D.C.      74    F        Sudden hearing loss   SSD
  G.F.      67    M        Ear surgery           SSD
  O.A.      60    F        Sudden hearing loss   SSD

###### 

Pre-operative audiometric data of subjects with mixed hearing loss, as bone-conduction and air-conduction threshold levels. PTA: pure tone audiometry.

  Patient   Bone conduction thresholds   Air conduction thresholds                                          
  --------- ---------------------------- --------------------------- ---- ---- ---- ----- ----- ----- ----- -----
  A.M.      5                            15                          15   50   35   70    60    50    60    55
  G.B.      35                           50                          55   60   60   105   95    85    90    115
  R.B.      10                           20                          35   30   25   55    60    55    65    60
  M.C.      5                            25                          35   45   40   65    60    65    65    75
  B.C.      5                            15                          20   35   30   45    45    50    60    35
  V.E.      40                           45                          45   65   75   105   100   110   105   110
  A.F.      5                            20                          35   45   40   45    55    65    65    80
  C.M.      20                           35                          40   60   70   85    90    70    90    100
  A.T.      20                           25                          20   25   35   65    70    60    50    110
  A.R.2     15                           35                          40   55   45   80    70    75    65    75
  A.R.1     10                           25                          40   55   50   60    85    90    100   100
  V.S.      15                           40                          55   65   75   55    60    80    65    95
  L.T.      50                           40                          35   55   50   50    60    55    70    90

A preoperative simulation test was performed with an individualised fitting of the two different SPs according to type and degree of hearing loss. In the Divino SP, volume level and gain at the low frequencies were manually changed for CMHL patients while, in the SSD ones, the gain at low frequencies was down-regulated in favour of high frequencies. The microphone was always set in the omnidirectional configuration. The BP100 SP was fully programmed using dedicated preset parameters for CMHL and SSD, optimising the fitting software in each patient. In mixed hearing loss, the wide band dynamic range compression was activated. Automatic noise management, active feedback cancellation, acoustic shock protection and the dynamic output stabiliser were also activated in all patients. Even with this SP, the microphone was set in the omnidirectional configuration.

Audiological assessment included:

-   Pure tone and speech audiometry, performed inside a soundproof booth with headphones, for choosing the ear (or the first ear) to be implanted;

-   Sound-field PTA, word recognition score (WRS) in quiet (at 65 dB HL), and WRS in noise (S/N ratio +10 dB) as maximum percentage of intelligibility at the stimulation level of 80 dB, as maximum output of the loudspeaker, for collecting data. For the speech in noise tests, babble noise and speech were delivered through separate channels calibrated independently, with a S/N ratio +10, to the loudspeakers located in the CMHL group at 0° (speech) and 180° (noise), while in the SSD group the multi-talker babble was directed to the better hearing ear, and speech to the poorer one. In the CMHL group, the better ear was always occluded during tests. The speech material consisted in three lists specific to the patients\' mother tongue [@R07].

Single values were recorded for the unaided, BC-HB and post-operative BCI outcomes.

All patients also underwent subjective evaluation of sound quality under the three different situations, using a visual analogue scale (VAS), with scores ranging from 0 to 10.

Mean values obtained in the CMHL and SSD groups with the BC-HB and the BCI compared with the unaided situation were used to assess the gain of the two aided situations compared with the unaided one. For statistical analysis, a non-parametric distribution of data was used. Spearman\'s Rho correlation coefficient (\> 0.80 with p value \< 0.05) was used to evaluate the correlation and significance of BC-HB values in predicting BCI performance, in the CMHL and SSD groups separately and together, for the following variables:

-   the PTA, separately, for low (250-1000 Hz) and high (2000-4000 Hz) frequencies, since at high frequencies different thresholds levels were recorded in the two aided situations [@R06] [@R13];

-   the percentage of WRS in quiet;

-   the maximum WRS in noise;

-   VAS as sound quality.

Spearman\'s rho (ρ) coefficient was also used to assess the correlation of the VAS with both the 2-4 kHz PTA and the WRS in quiet, at baseline, BC-HB and BCI conditions.

The study was performed in accordance with the principles of the 1983 Declaration of Helsinki.

Results {#S3}
=======

Conductive-mixed hearing loss (CMHL) PTA {#S3a}
----------------------------------------

The mean PTA values in the unaided, BC-HB and BCI conditions are shown in [Figure 1](#F1){ref-type="fig"}. Improvement was found with the BC-HB and the BCI compared with the unaided situation. The mean gain at low-mid frequencies (250- 1000 Hz) was 19.47 dB with the BC-HB and 22.01 dB with the BCI; at high frequencies (2000-4000 Hz) it was 14.42 dB with the BC-HB and 22.07 with the BCI. The BCI gain exceeded that with the BC-HB by 2.54 dB at low frequencies and by 8.27 dB at high frequencies.

###### 

a\) Pure tone average (PTA) in conductive-mixed hearing loss (CMHL) subjects in the unaided, headband and bone-conductive implant (BCI) conditions. b) Pure tone average (PTA) in single-sided deafness (SSD) subjects in the unaided, headband and bone-conductive implant (BCI) conditions.
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Speech audiometry in quiet -- WRS {#S3b}
---------------------------------

The mean WRS values at 65 dB in quiet are shown in [Figure 2](#F2){ref-type="fig"}. The WRS values improved with both the BCHB and BCI. When considering the BC-HB and the BCI compared with the unaided condition, the mean WRS gain was 21% with the BC-HB, and 37% with the BCI, with a 16% difference ([Fig. 2](#F2){ref-type="fig"}).

###### 

a\) Percentage of word recognition score (WRS) at 65 dB HL in quiet, in conductive-mixed hearing loss (CMHL) subjects, in the unaided, headband and bone-conductive implant (BCI) conditions. b) Percentage of WRS at 65 dB HL in quiet, in single- sided deafness (SSD) subjects, in the unaided, headband and BCI conditions.
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Speech audiometry in noise (S/R + 10) -- Maximum WRS {#S3c}
----------------------------------------------------

The mean maximum percentage of word recognition in noise in the three different conditions is shown in [Figure 3](#F3){ref-type="fig"}. The percentage of intelligibility improved with both the BC-HB and BCI. The mean gain compared with the unaided condition was 12.3% with the BC-HB and 24.5% with BCI, with a difference of 12.2% between the two aided conditions ([Fig. 3](#F3){ref-type="fig"}).

###### 

a\) Maximum percentage of word recognition score (WRS) in noise, at stimulation level of maximum WRS in quiet, in conductive-mixed hearing loss (CMHL) subjects, in the unaided, headband and bone-conductive implant (BCI) conditions. b) Maximum percentage of WRS in noise, at stimulation level of maximum WRS in quiet, in single-sided deafness (SSD) subjects, in the unaided, headband and BCI conditions.
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Single sided deafness PTA {#S3d}
-------------------------

The PTA results in all three situations are shown in [Figure 1](#F1){ref-type="fig"}. PTA improvement was found with both the BC-HB and BCI at low and high frequencies. The mean gain at low frequencies was 3.17 dB with the BC-HB and 4.44 dB with the BCI; at high frequencies, the gain was 4.44 dB with the BC-HB and 8.33 dB with the BCI. The gain difference between the two aided modalities was 1.27 dB at low frequencies and 3.9 dB at high frequencies.

Speech audiometry in quiet -- WRS {#S3e}
---------------------------------

The mean WRS results in all three conditions are shown in [Figure 2](#F2){ref-type="fig"}. The percentage of word recognition at 65 dB improved with both the BC-HB and BCI. The WRS gain was 9% with the BC-HB and 14% with the BCI; the difference between the two aided modalities was 5%.

Speech audiometry in noise (S/N + 10) {#S3f}
-------------------------------------

The mean maximum percentage of word recognition in noise in the three different conditions is shown in [Figure 3](#F3){ref-type="fig"}. The mean gain was 1.11% with the BC-HB and 11.11% with the BCI compared with the unaided condition. A 10% percentage difference between the two aided modalities was found. The mean gain was 2 dB with the BC-HB and 5.5 dB with BCI.

VAS of sound quality {#S3g}
--------------------

The mean VAS values obtained under the unaided, BCHB and BCI conditions, in the CMHL and SSD groups, are shown in [Figure 4](#F4){ref-type="fig"}.

###### 

a\) Mean visual analogue scale (VAS) score for conductive- mixed hearing loss (CMHL) subjects in the unaided, headband and bone-conductive implant (BCI) conditions. b) Mean VAS score for single-sided deafness (SSD) subjects in the unaided, headband and BCI conditions.
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In the CMHL group, a strict correlation (ρ =0.85, p \< 0.001) between the PTA thresholds at 250-1000 Hz of the BC-HB and BCI was found, which was also significant for all other parameters ([Table III](#T3){ref-type="table"}). In the SSD group, the correlation between BC-HB and BCI was also very close and significant for all parameters, except for PTA values at 250-1000 Hz. When considering the patients together, strong correlation was found for the entire PTA range, which was significant for all parameters considered ([Table IV](#T4){ref-type="table"}).

###### 

Correlation level (Spearman\'s rho) and significance (p) of the intra-individual changes in variables between the BC-HB and the BCI, for conductive-mixed hearing loss (CMHL, n = 13) and single-sided deafness (SSD, n = 9) subjects. PTA: Pure tone average; WRS: word recognition score.

  Predictive Index of pre-operative BC-HB for the BCI outcome          
  ------------------------------------------------------------- ------ ----------
  CMHL (n = 13)                                                        
  Sound quality (VAS)                                           0.68   0.011
  PTA 250-500-1000 Hertz (dB)                                   0.85   \< 0.001
  PTA 2-4 KHz (dB)                                              0.68   0.011
  WRS in quiet                                                  0.69   0.010
  WRS in noise (%)                                              0.73   0.005
  SSD (n = 9)                                                          
  Sound quality (VAS)                                           0.90   0.001
  PTA 250-500-1000 Hertz (dB)                                   0.56   0.119
  PTA 2-4 KHz (dB)                                              0.88   0.002
  WRS in quiet                                                  0.92   0.001
  WRS in noise (%)                                              0.87   0.002

###### 

Correlation level (Spearman\'s rho) and significance (p) of the intra-individual changes in variables between the BC-HB and the BCI, in the entire study group. PTA: pure tone average; WRS: word recognition score.

  Correlation between the intra-individual changes after the BC-HB and the BCI in all subjects          
  ---------------------------------------------------------------------------------------------- ------ ----------
  PTA 250-500-1000 hertz (dB)                                                                    0.85   \< 0.001
  PTA 2000-4000 hertz (dB)                                                                       0.83   \> 0.001
  WRS in quiet (%)                                                                               0.61   0.003
  WRS in noise (%)                                                                               0.76   \< 0.001

In the CMHL, a high and significant correlation was found between the WRS in quiet and VAS in the unaided (ρ = 1.00; p \< 0.001), BC-HB (ρ =0.99; p \< 0.001) and BCI (ρ = 0.99; p \< 0.001) conditions. A significant correlation was also found between PTA 2-4 kHz and the VAS in the unaided (p= 0.010), BC-HB (p= 0.004) and BCI (p \< 0.001) conditions.

In SSD, a high and significant correlation was found between the WRS in quiet and the VAS in the unaided (ρ = 1,00; p \< 0.001), BC-HB (ρ =1.00; p \< 0.001) and BCI (ρ = 0.87; p \< 0.003) conditions. No correlation was found between the VAS and PTA 2-4 kHz in the unaided (p \> 0.05), BC-HB (p = 0.05) or BCI (p \> 0.05) conditions.

Discussion {#S4}
==========

The differences between the transcutaneous and percutaneous modality of sound conduction of bone generally influence the mean auditory gain, even when a single frequency range is taken into consideration. At high frequencies, for instance, percutaneous BCI usually provides better gain than a transcutaneous system [@R08]. In clinical practice, a preoperative trial period and audiometric tests carried out with the transcutaneous simulation system, such as the headband (HB), allow the patient to get acquainted with the sound delivered by the device, and also help the audiologist and surgeon to select the right candidate and anticipate the definitive post-operative result. Pre-operative HB tests enable recording data with a transcutaneous mode of stimulation, and to compare them at a later stage with those obtained via the definitive BCI. Similarly to all HA-related tests, even in this situation audiometric tests are performed in sound fields with variables related to intrinsic (type and severity of hearing loss, uni- or bilateral hearing loss) and extrinsic factors (type and level of stimulation, loudspeaker position in the azimuth). Generally, in spite of striking methodological differences, few information is usually available in the literature that describes the specific setting of the simulation device, which is instead analysed with fixed stimulation parameters, such as delivering the maximum volume without balancing the frequency gain in relation to the patients\' hearing loss and listening need. One may assume that this latter adjustment is meant to compensate for the inferior efficacy of the transcutaneous bone stimulator compared with the percutaneous one. Furthermore, the information collected by simulation tests should be different in individuals affected by CMHL from those with SSD due to the different problems associated with the two hearing conditions, such as for instance loss of binaural hearing that is usually targeted only in SSD. The literature in this regard has mainly focused on CMHL, because after more than 30 years of application of a BCI in this form of hearing impairment, the major target has uniquely been PTA gain [@R09]^-^[@R11]. A recent study compared the pre-operative transcutaneous and postoperative percutaneous conditions, reporting differences in the hearing threshold (5-20 dB for the range 1-4 kHz and 6 dB for that 0.5-1 kHz) as well as in speech recognition thresholds (SRT improvement of 4-7 dB) [@R12]. Other investigators have found that the predictive value at low-frequency was more reliable than at high frequencies, with a hearing gain ranging from 1 to 18 dB [@R13]. Snapp et al. [@R14] commented on the low sensitivity of common audiological tests for predicting and monitoring BCI outcomes in SSD patients, stressing that the tests with speech recognition in noise should play a major role for appropriate assessment.

At our department, all patients candidate for a BCI, being affected by either conductive, mixed or profound unilateral sensorineural hearing loss (SSD), routinely undergo a preoperative trial wearing a HB coupled to the same sound processor that has been chosen to be coupled to the implanted fixture. The specific sound processor is individually fitted, selecting the parameters that would mostly be beneficial for the individual patient. In the present study, two types of sound processors of the same manufacturer were used: the BP100 and the Divino. For the BP100 SP, the fitting parameters set by default for conductive-mixed hearing loss and SSD were modified on the basis of the patient\'s listening characteristics; for the Divino SP, the volume at the low frequencies was manually regulated depending on the type of hearing loss: in SSD, the gain at low frequencies was decreased to allow better speech perception, especially in noisy environments, while in CMHL, low frequency amplification was only finalised to improve the signal to noise ratio. Due to the limitation of the available devices, which do not allow a home-trial period, the potential candidate was left with the BC-HB for a few hours in different listening environments, before performing a series of audiological tests that have always included the measurement of verbal perception, in quiet and noise, as well as a questionnaire on the quality of the perceived sound in the different listening situations.

The present study has taken into consideration hearing function assessed both with the BC-HB and with the activated BCI, in terms of:

-   hearing threshold as PTA (250-4000 Hertz);

-   percentage of WRS at 65 dB in quiet;

-   maximum percentage of WRS in noise (S/N +10, fixing the stimulation loudness at 80 dB, corresponding to the maximum output of the loudspeaker in sound-field);

-   quality of perceived sound with VAS compared with the unaided condition, and the statistical difference of the same parameters between the simulation pre-operative effects and definitive post-operative outcome.

The effect of the BCI, in the simulation and definitive configurations, was significantly better than in the unaided condition for all the qualitative and quantitative parameters. Apart from this easily predictable result, the major target of this study was to assess how close the two aided conditions would perform, so as to highlight the predictive role of the BC-HB.

In conductive and mixed hearing loss, a mean intra-individual improvement after BCI was found for the PTA between 250 and 4000 Hz, for word discrimination in quiet and noise, and for the quality of sound. The PTA differences between the BCI and the BC-HB were minimal (around 2.5 dB for low frequencies and 8 dB for high frequencies), while the speech performance with the BCI was better than with the BC-HB (16% in quiet and 12% in noise).

In the SSD group, the performance of the BCI was superior to that of the BC-HB in all parameters considered. The mean PTA gain with the BCI, compared with the BC-HB condition, was minimal (around 1 dB) for low frequencies and up to only 4 dB for high frequencies. When testing speech discrimination, a better percentage of intelligibility was found with the BCI than with the BC-HB, of about 5% in quiet and 10% in noise. The mean VAS values in the CMHL and SSD groups, taken together, showed that the definitive BCI provided a clearer and better sound than both the unaided and the BC-HB condition.

The prediction of the BCI effect derived from the correlation between the intra-individual changes of the variables in the two aided situations was extremely significant in the CMHL group for low-middle frequencies, and to a lesser degree, but still significant, for the other parameters; in the SSD group, however, the correlation for low frequencies was poor. This latter finding is related to the fitting characteristics for the SSD situation and to the minimal gain deliberately received at low frequencies to privilege high frequency gain, while trying to optimise some of the binaural function features. Considering the patients together (CMHL + SSD), close correlation was found for the entire PTA range, which was significant for all parameters.

The correlation between VAS and the other variables revealed differences between the CMHL and SSD groups in the three different situations. In CMHL, in all situations, a close and significant correlation was found between the good perceived quality of sound in terms of clearness and openness and speech perception in quiet. When considering the correlation between VAS and 2000-4000 Hz PTA, it was shown to be significant in all auditory situations, but correlated highly only with the BCI. The correlation between sound quality, sound-field speech perception and high-frequency gain with a BCI has already been recently shown [@R13]. In the SSD group, in contrast, a high and significant correlation of VAS was shown only with the WRS percentage in quiet, in all three situations. This finding means that in the SSD, verbal and speech perception are related with directional hearing and follow two separate analytic processing cues, the first simply auditory and the second linked to multi-sensorial inputs.

Apart from the efficacy of the BCI compared to the unaided situation in the CMHL and SSD groups, the present study showed that the use of a personalised, well-fitted SP coupled to a HB in pre-operative simulation tests is reliable in predicting the final BCI advantages not only for hearing improvement, but also for speech perception in noise and quality of listening. The accuracy of the outcome prediction is motivated by the fact that, contrary to previous reports, the differences between PTA and WRS in the two aided conditions were minimal [@R14]. This assumption is also confirmed by the strong and significant correlation with all variables taken into consideration, as well as in the VAS when comparing hearing function with the BC-HB with that of the definitive implant.

It is possible to comment that the main reason for preoperatively assessing a BCI candidate with a transcutaneous HB-coupled processor is to allow the subject to experience the actual advantages of bone conduction stimulation carried out using a modality that is mostly reproduced by the definitive BCI. In our opinion, these simulation tests can be reliable only if the drawback of the skin attenuation related to the transcutaneous condition is partially compensated by fitting the SP simulator on the basis of individual hearing loss, as well as the needs and individual targets of each candidate, rather than using a preset configuration.

Conclusions {#S5}
===========

The present study shows that when using pre-operative audiological assessment with a BC-HB simulator as a predictor of a BCI outcome, the simulation device should be fitted with the same modality used for the definitive BCI, while assessing audiological performances not only as PTA auditory gain, but mostly as speech perception in noise and improvement of the quality of perceived sound.

The outcome of such an evaluation may allow patients, audiologists and surgeons to obtain an accurate estimate of the final outcome after BCI application.
